Virginia Gov. Ralph Northam announced on Aug. 29 that Micron Technology plans to expand its Manassas plant, spending $3 billion and adding 1,100 high-paying jobs by 2030.
Chris Lloyd, senior vice president and director of McGuireWoods Consulting’s infrastructure and economic development team, was quoted in an Aug. 28 Washington Business Journal article on the transformation of Fairfax County from a Washington, D.C., suburb, to a national economic powerhouse under the leadership of Gerald Gordon.
Frank Donatelli, executive vice president and director of McGuireWoods Consulting's federal public affairs team, was interviewed on Aug. 25 by Fox News’ Jon Scott and on Aug. 26 by MSNBC’s Alex Witt on the passing of Sen. John McCain.
In her Aug. 13 Law360 article, Lai King Lam, vice president in McGuireWoods Consulting’s federal public affairs practice, assessed the prospects of passage for Tax Reform 2.0, a follow-up to the GOP’s 2017 tax law.
In an Aug. 7 Law360 article, Michele Satterlund examined steps state and local governments are taking to open the use of sidewalks to new technologies such as delivery robots and stand-up scooters.
The General Assembly returned to Raleigh on Saturday, August 4, 2018 to consider veto overrides of House Bill 3 and Senate Bill 3. The House voted in favor 70-39 to override the bills. Both the House and the Senate adjourned the extra session sine die. Legislators are not expected to re-convene until November 27, 2018.
This Week: CMS releases final rules for SNF, IRF and others; House in recess; Senate in recess, but will be back this month.
Your weekly North Carolina political news report.
This Week: CMS releases proposed rules; House passes legislation concerning ACA taxes and broader use of HSAs; Opioid legislation waits in the Senate.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.